| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
7e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
8e-05 |